Create a free ProFood World account to continue reading

Prostate cancer project aims to reduce dose and food effects

Quotient Clinical, the Translational Pharmaceutics Company, has announced the initiation of a new RapidFACT program for Druggability Technologies (DRGT) for evaluating enhanced formulations of abiratone acetate, a marketed drug prescribed in combination with prednisone to patients suffering from metastatic prostate cancer.

Read More at Pharmpro

The building envelope is a production asset
Condensation, energy loss, and sanitation failures often trace back to the same place. This free article shows where to look.
Read More
The building envelope is a production asset